Literature DB >> 20347547

Open vs endovascular repair of abdominal aortic aneurysm involving the iliac bifurcation.

Frédéric Cochennec1, Jean Marzelle, Eric Allaire, Pascal Desgranges, Jean-Pierre Becquemin.   

Abstract

INTRODUCTION: Aneurysmal involvement of the iliac bifurcation increases the level of difficulty during surgery for abdominal aortic aneurysm (AAA) repair, potentially increasing the risk of early postoperative complications. Three previous randomized trials comparing endovascular aneurysm repair (EVAR) and open repair (OR) for AAAs showed that EVAR is associated with a lower early mortality rate. However, whether these results are valid for AAA involving the iliac bifurcation (AAAIB) remains unclear. The aim of this study was to evaluate early and late results after OR and EVAR for patients with AAA involving the iliac bifurcation.
METHODS: Of 1116 patients treated for elective AAA repair between January 1998 and January 2008, 131 presented with AAAIB as detected by computed tomography (CT) scan. Sixty-eight patients were treated by EVAR and 63 by OR. Clinical and anatomic data, operative intervention, and outcomes were collected prospectively and analyzed retrospectively. The median duration of follow-up was 38 months for both groups.
RESULTS: Patients in the EVAR group (72 +/- 10 years) were older than those in the OR group (64 +/- 8 years; P < .0001), but there were no differences in cardiac, renal, or pulmonary comorbidities between the two groups. Inhospital mortality rates were 2.9% vs 6.3% for EVAR and OR groups, respectively (P = .43). Systemic postoperative complications occurred in 7.4% vs 9.5% (P = .76) and postoperative colonic ischemia in 0% vs 6.3% (P = .051) of patients with EVAR and OR, respectively. Survival rates by Kaplan-Meier analysis were 91 +/- 7% for patients with EVAR and 90 +/- 8% for patients with OR at 2 years, and 61% +/- 15 for EVAR and 79% +/- 13 for OR at 5 years. All-cause reoperation rates were 25% with EVAR and 22% with OR (P = .83). Patients with EVAR were more likely to develop buttock claudication (33.3% vs 3.6%; P < .0001), whereas patients with OR were more prone to develop abdominal wall complications (19.6% vs 0%; P < .001).
CONCLUSION: In this series, the postoperative mortality and systemic complication rates after either EVAR or OR for AAAIB were not statistically different. In the OR group, there were more abdominal wall complications and a trend toward a higher rate of colonic ischemia. In the EVAR group, buttock claudication was more frequent. Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20347547     DOI: 10.1016/j.jvs.2010.01.032

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  [Interventional endovascular therapy of infrarenal abdominal aortic aneurysm].

Authors:  W Gross-Fengels; H Daum; P Siemens; L Heuser; K U Wagenhofer
Journal:  Radiologe       Date:  2013-06       Impact factor: 0.635

2.  Two cases of endovascular abdominal aortic aneurysm repair with iliac aneurysm using a zenith iliac bifurcation graft.

Authors:  Kei Kazuno; Norifumi Ohtani; Sentaro Nakanishi
Journal:  Ann Vasc Dis       Date:  2012-11-30

3.  8-Year Long-Term Outcome Comparison: Two Ways to Exclude the Internal Iliac Artery during Endovascular Aorta Repair (EVAR) Surgery.

Authors:  Han Luo; Bin Huang; Ding Yuan; Yi Yang; Fei Xiong; Guojun Zeng; Zhoupeng Wu; Xiyang Chen; Xiaojiong Du; Xiaorong Wen; Chuncheng Liu; Hongliu Yang; Jichun Zhao
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

4.  Outcomes of Elective Endovascular Aneurysmal Repair for Abdominal Aortic Aneurysms in Jordan.

Authors:  Kristi E Janho; Mohammed A Rashaideh; Jan Shishani; Muhannad Jalokh; Hazem Haboub
Journal:  Vasc Specialist Int       Date:  2019-12-31

5.  Preservation of internal iliac artery flow during endovascular aortic aneurysm repair in a patient with bilateral absence of common iliac artery.

Authors:  Minh-Anh Pham; Thanh-Phong Le
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.